Engineering
Chemicals
Biotechnology

Amyris

$4.25
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.16 (-3.63%) As of 1:53 PM EDT today
-$0.16 (-3.63%) Today

Why Robinhood?

You can buy or sell Amyris and other stocks, options, ETFs, and crypto commission-free!

About AMRS

Amyris, Inc. Common Stock, also called Amyris, is an industrial biotechnology company, which engages in the provision of bioscience solutions. Read More It focuses on the research, development, manufacture, and sale of fuels and farnesene-derived products. Its products include cosmetics, flavors and fragrances, performance materials, diesel, jet fuel, and lubricants. The company was founded by Jack D. Newman, Kinkead Keith Reiling, and Neil Renninger on July 17, 2003 and is headquartered in Emeryville, CA.

Employees
Headquarters
Emeryville, California
Founded
2003
Market Cap
337.48M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
1.22M
High Today
$4.40
Low Today
$4.14
Open Price
$4.40
Volume
683.31K
52 Week High
$9.29
52 Week Low
$1.87

Collections

Engineering
Chemicals
Biotechnology
Cosmetics
Materials
Health
Retail
US

AMRS News

BenzingaAug 8

Amyris, Inc. - Lavvan Appoints Former MedReleaf CEO Neil Closner To Its C-Suite

656

AMRS Earnings

-$0.76
-$0.30
$0.15
$0.61
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
-$0.42 per share
Actual
Expected Aug 14

Popular Stocks

More AMRS News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.